Glass House Brands Applies for NYSE Uplisting

LONG BEACH – Glass House Brands Inc., a vertically integrated Cannabis company concentrated in California, announced it has applied to list its subordinate voting shares on the New York Stock Exchange. The filing is among the most concrete steps any U.S. multistate Cannabis operator has taken toward a place on a major American exchange.

Glass House currently trades on Cboe Canada and the OTCQX market in the United States. An NYSE listing would open the stock to institutional investors and index funds barred from holding shares that trade only over the counter or on Canadian exchanges, a restriction that has kept much of the U.S. Cannabis industry out of mainstream portfolios since its earliest public offerings.

To support the listing application, Glass House and an indirect subsidiary, GHB Usub LLC, completed a restructuring that separates the company’s “dual-use” Cannabis business, retail and brand operations serving both recreational and medical customers, from its medical-only operations. The dual-use business now sits inside Glass House Retail LLC, a former subsidiary the company no longer consolidates on its financial statements. A third-party investor holds the voting interest in that entity, while the Glass House subsidiary keeps a non-voting economic stake.

That non-voting stake can only convert into voting shares once the NYSE changes its rules to permit listed companies to consolidate the financials of businesses that cultivate, distribute or process Cannabis for non-medical use, language drawn from the federal Controlled Substances Act. Glass House, in effect, kept its largest revenue lines off its consolidated books for listing purposes while preserving a contractual right to bring them back if exchange rules change down the road.

The application arrives as Cannabis’s status under federal law remains unsettled. Glass House has already applied for DEA registration to operate its medical Cannabis business under a Schedule III classification, and a federal administrative hearing on broader rescheduling is set for June 29. Other MSOs, including Green Thumb Industries, Curaleaf and Trulieve, have pursued their own routes toward U.S. exchanges, and Cannabis stocks became tradable on Robinhood for the first time earlier this year, a step executives called early progress toward an eventual listing on a major exchange.

The deconsolidation says more about Glass House’s legal strategy than about the odds of approval, and that strategy isn’t original to Glass House. Trulieve carried out a nearly identical restructuring earlier this month, separating its mixed-use Harvest subsidiary from its medical business, and the NYSE approved the application. Trulieve began trading under the ticker TRLV as the first U.S. plant-touching Cannabis operator listed on a major exchange.

Glass House’s filing follows that same approach, which removes some of the uncertainty around whether the structure itself can pass NYSE review, but leaves open how many other MSOs with sizable dual-use retail footprints now attempt the identical restructuring, and how quickly the exchange processes a second application built the same way. The arrangement also relies on continued cooperation from the third-party investor holding the voting interest in Glass House Retail. The open question for the Cannabis sector is no longer if this kind of corporate split can work, Trulieve already answered that, but how many companies can run the same maneuver before it stops feeling like an exception.